Biological and pharmacological aspects of the NK1‐receptor

S Garcia-Recio, P Gascón - BioMed research international, 2015 - Wiley Online Library
The neurokinin 1 receptor (NK‐1R) is the main receptor for the tachykinin family of peptides.
Substance P (SP) is the major mammalian ligand and the one with the highest affinity. SP is …

Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs

J Longmore, RG Hill… - Canadian journal of …, 1997 - cdnsciencepub.com
The mammalian tachykinins (substance P, neurokinin A, and neurokinin B) are widely
distributed throughout the central and peripheral nervous systems, where they act as …

The tachykinin NK1 receptor in the brain: pharmacology and putative functions

A Saria - European journal of pharmacology, 1999 - Elsevier
After its discovery in 1931, substance P (SP) remained the only mammalian member of the
family of tachykinin peptides for several decades. Tachykinins thus refer to peptides sharing …

The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles

L Quartara, CA Maggi - Neuropeptides, 1998 - Elsevier
The tachykinin NK1 receptor is widely distributed in both the central and peripheral nervous
system. In the CNS, NK1 receptors have been implicated in various behavioural responses …

Tachykinin receptors and receptor subtypes.

R Patacchini, CA Maggi - Archives internationales de …, 1995 - europepmc.org
The tachykinins, substance P, neurokinin A and neurokinin B, are a family of neuropeptides
widely distributed in the mammalian central and peripheral nervous system. In the …

The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation

L Quartara, CA Maggi - Neuropeptides, 1997 - Elsevier
The tachykinin NK1 receptor is widely expressed in the mammalian central and peripheral
nervous system. Powerful pharmacological tools (agonists and antagonists) are now …

Tachykinins and tachykinin receptors: structure and activity relationships

TA Almeida, J Rojo, PM Nieto, FM Pinto… - Current medicinal …, 2004 - ingentaconnect.com
In addition to the classical neurotransmitters, acetylcholine and noradrenaline, a wide
number of peptides with neurotransmitter activity have been identified in the past few years …

The NK-1 receptor: a new target in cancer therapy

M Munoz, M Rosso, R Covenas - Current drug targets, 2011 - ingentaconnect.com
After binding to the specific neurokinin-1 (NK-1) receptor, the peptide substance P (SP),
which is widely distributed in both the central and peripheral nervous systems, induces …

Potential therapeutic targets for neurokinin-1 receptor antagonists

RA Duffy - Expert opinion on emerging drugs, 2004 - Taylor & Francis
The peptide substance P and its tachykinin receptor, neurokinin-1 (NK1), have been the
focus of considerable research for their role in a variety of both central and peripheral …

NK-1 receptor antagonists: a new paradigm in pharmacological therapy

M Munoz, R Covenas - Current medicinal chemistry, 2011 - ingentaconnect.com
The neuropeptide substance P (SP) shows a widespread distribution in both the central and
peripheral nervous systems and it is known that after binding to the neurokinin-1 (NK-1) …